Sign Up to like & get
recommendations!
1
Published in 2022 at "Molecular Oncology"
DOI: 10.1002/1878-0261.13183
Abstract: Metastases account for the majority of prostate cancer (PCa) deaths, and targeting them is a major goal of systemic therapy. We identified a novel interaction between two kinases: tousled‐like kinase 1 (TLK1) and MAP kinase‐activated…
read more here.
Keywords:
tlk1 mk5;
prostate cancer;
mk5;
motility ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "IUBMB Life"
DOI: 10.1002/iub.1677
Abstract: MAP kinase‐activated protein kinases (MKs), protein serine/threonine kinases downstream of the MAPKs, regulate a number of biological functions. MK5 was initially identified as a substrate for p38 MAPK but subsequent studies revealed that MK5 activity…
read more here.
Keywords:
function mk5;
novel regulator;
mk5 novel;
cardiac ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Circulation Research"
DOI: 10.1161/res.127.suppl_1.518
Abstract: MAP kinase-activated protein kinase-5 (MK5) is a protein serine/threonine kinase involved in fibroblast function. MK5 is activated by phosphorylation at threonine-182 (Thr182): p38α/β, ERK3, and ERK4 have been implicated. We examined the phosphorylation of MK5…
read more here.
Keywords:
phosphorylation mk5;
threonine 182;
immunoreactivity;
phos tag ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Cancers"
DOI: 10.3390/cancers14235728
Abstract: Background Metastatic dissemination of prostate cancer (PCa) accounts for majority of PCa related deaths. However, the exact mechanism of PCa cell spread is still unknown. We uncovered a novel interaction between two unrelated promotility factors,…
read more here.
Keywords:
metastasis;
tlk1 mk5;
mk5;
pca ... See more keywords